» Articles » PMID: 16164933

Therapeutic Options for Occult Breast Cancer: a Survey of the American Society of Breast Surgeons and Review of the Literature

Overview
Journal Am J Surg
Specialty General Surgery
Date 2005 Sep 17
PMID 16164933
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Axillary presentation of occult breast cancer (OBC) is uncommon, and continues to be a diagnostic and therapeutic challenge to physicians. After our recent experience with a similar patient, a survey of the American Society of Breast Surgeons (ASBS) was conducted to assess the Society's member's opinions on treatment.

Methods: A survey was sent by mail to 1837 members of the ASBS. The survey consisted of a brief case presentation after which the surgeon's preference for management of the breast was sought. The choices included "mastectomy," "whole breast radiation" or "other."

Results: A total of 776 (42%) responses were received. The majority of respondents, 338 or 43%, preferred "mastectomy," while 285 or 37% opted for "whole breast radiation." Twenty percent of respondents (153 responses) chose "other," of which 46 physicians (6% of total) indicated they would observe the patient.

Conclusions: Although recent literature supports the use of whole breast radiation, these results demonstrate that a small majority of physicians still prefer mastectomy. The appropriate treatment of the breast after an axillary presentation of OBC continues to be a controversial issue.

Citing Articles

Case report: Unraveling a unique case of male occult breast cancer with axillary intricacies and a comprehensive literature dive.

Xie X, Kong X, Jiang H, Gao J Front Oncol. 2025; 15:1374032.

PMID: 40008002 PMC: 11851083. DOI: 10.3389/fonc.2025.1374032.


Occult breast cancer in an older woman: A case report.

Liu C, Xing H Exp Ther Med. 2025; 29(2):38.

PMID: 39781192 PMC: 11707571. DOI: 10.3892/etm.2024.12788.


Trends in management and related outcomes for occult primary breast cancer.

LaBella M, Lile-King R, Agala C, Spanheimer P, Ollila D, Gallagher K Breast Cancer Res Treat. 2024; 209(2):367-374.

PMID: 39397208 PMC: 11875011. DOI: 10.1007/s10549-024-07500-w.


Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.

Tang L, Zhu Y, Du Y, Long X, Long Y, Tang Y J Cancer Res Clin Oncol. 2024; 150(5):256.

PMID: 38750402 PMC: 11096249. DOI: 10.1007/s00432-024-05783-6.


Occult breast cancer with pleural metastasis.

Faghani R, Monadi S Radiol Case Rep. 2023; 18(9):3065-3069.

PMID: 37434614 PMC: 10331009. DOI: 10.1016/j.radcr.2023.06.001.